Public Health Price Protection Act of 1979

Public Health Price Protection Act of 1979 - Amends the Public Health Service Act to direct the Secretary of Health, Education, and Welfare to certify to the Federal Trade Commission that the average price to the consumer of a patented drug is more than 500 percent of the direct cost thereof to the producer when such a situation exists. Requires the Federal Trade Commission, upon verification of such certification, to determine whether the existence of a patent has been a substantial contributing factor to the high price of such drug, and if the patent has so contributed, to order the mandatory licensing of such patent with a reasonable royalty rate.